A randomized controlled trial of Berubicin, a doxorubicin analog that effectively crosses the blood-brain barrier (BBB), after first-line therapy for glioblastoma multiforme (GBM): Preliminary Results

doxorubicin hydrochloride - Generic mfg.

berubicin (RTA 744) - CNS Pharma, WPD Pharma

lomustine - Generic mfg.

Sandra Silberman, MD PhD; Sigmund Hsu, MD; Don Picker, PhD; Zena Muzyczenko; Waldemar Priebe, PhD

Sep 28, 2022